The Foresight Technology VCT (“FWT VCT”) offers investors the opportunity to gain exposure to an exciting portfolio of early-stage companies, developing disruptive technologies with high growth potential. The Fund benefits from the unique collaboration between Foresight, a FTSE 250 listed infrastructure and SME investment manager, with over £12bn in AUM, and WAE, a world class technology and engineering business originally spun out of the Williams F1 team.
FWT VCT invests at an earlier stage (pre‑revenue to pre‑profit) into deep technology companies, which, combined with the relative youth of the portfolio, provides investors access to a more traditional venture capital return profile with the potential for higher returns.
Portfolio Spotlight
Identifying and measuring protein molecules is an integral part of life sciences research, particularly in the development of new medicines. Refeyn, who have been a part of FWT VCT’s portfolio since 2020, are commercialising a disruptive technology that uses light to measure a molecule’s mass (mass photometry).
Since the initial investment, Refeyn has worked with the team at WAE on product design and manufacture, and electrical systems design and development. The engagement resulted in a sleek industrial design for the Refeyn One instrument and optimisation of the electronic system design specification, and the company has since expanded its offering of mass photometry systems.
